跳至主要内容
临床试验/NCT00425165
NCT00425165终止2 期

A Randomized, Double-Blind, Two Way Crossover Evaluation of the Effects of a Single Dose of Denufosol Tetrasodium (INS37217) Inhalation Solution Versus Placebo (0.9% Sodium Chloride Solution) on Mucociliary Clearance in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

Merck Sharp & Dohme LLC0 个研究点目标入组 6 人开始时间: 2007年8月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
6
主要终点
Change in mucociliary clearance from baseline

研究概览

简要总结

The purpose of this trial is to evaluate the effects of a single dose of denufosol versus placebo on mucociliary clearance in patients with mild to moderate CF lung disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •have confirmed diagnosis of cystic fibrosis
  • •have FEV1 of greater than or equal to 60% of predicted normal for age, gender, and height
  • •be able to reproducibly perform spirometry maneuvers
  • •be clinically stable for at least 4 weeks prior to screening

排除标准

  • •have abnormal renal or liver function
  • •have chest x-ray at screening with abnormalities suggesting clinically significant active pulmonary disease
  • •have had a lung transplant

结局指标

主要结局

Change in mucociliary clearance from baseline

时间窗: 30, 60, and 90 minutes post aerosol inhalation

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验